Drug-induced Nephrotoxicity Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Drug-induced Nephrotoxicity Treatment Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.

Drug-induced nephrotoxicity or drug-induced kidney disease (DIKD) is primarily recognized as an important contributor to kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD). Drug-induced nephrotoxicity is often unrecognized, especially in the context of short drug exposure, which creates difficulties in assessing the incidence, severity, and long-term outcome of drug-induced renal disease. Mechanisms of drug-induced nephrotoxicity include glomerular hemodynamic changes, tubular cytotoxicity, inflammation, lens nephropathy, rhabdomyolysis, and thrombotic microangiopathy.

Market Segments

Based on biomarkers

• Immunoglobulin G
• Albumin
• Microglobulins
• Cystatin C Retinol binding protein
• Cytokines
• Interferons
• Interleukins
• N-Acetyl-D-Glucosaminidase
• Clusterin
• Osteopontin
• Kidney Injury Molecule-1 (KIM-1)
• Neutrophil gelatinase-associated lipocalin (NGAL)

Key Players

• Roche Diagnostic Limited
• Siemens Healthcare
• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Aushon BioSystem Inc.
• Epistem Ltd
• G.E. Healthcare Inc.
• Affymetrix Inc.

Scope of the Report

The research study analyzes the global Drug-induced Nephrotoxicity Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Drug-induced Nephrotoxicity Treatment Market Report

1. What was the Drug-induced Nephrotoxicity Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Drug-induced Nephrotoxicity Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Drug-induced Nephrotoxicity Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.